Yahoo Suche Web Suche

  1. Optimize Your Investment, Adapt to The Future and Turn Change Into Progress. PowerMax Features High-Speed Smarts To Power Your Most Critical Workloads. Explore Now.

Suchergebnisse

  1. Suchergebnisse:
  1. Vor 2 Stunden · Mfe-Mediaforeurope Nv. Follow. Show more companies. PRAGUE, May 14 (Reuters) - German media group ProSiebenSat.1 , opens new tab should forge ahead with selling its e-commerce and online dating ...

  2. Vor 16 Stunden · Ppf è il secondo maggiore azionista di ProSieben con una quota del 15%, dietro a Mfe-MediaForEurope che detiene quasi il 30%. Mfe ha proposto di scorporare le attività di e-commerce e di dating online di ProSieben all'assemblea di aprile, proposta che è stata respinta per un soffio dai soci.

  3. Vor 16 Stunden · cf4b63c308f54.zJ936aq6_Vb8Tkjgw9afnTPGGUcNBAbqlCFjdUy4-k0.hcwjg_2CsGe-JyamsbH-zgCoQQhEY1KorWsvRXXz1wqo1h-KwIqKGMoCeA

  4. Vor 16 Stunden · 8fc45d01d8c.KiZL_3Y8swxDnL-vBDQkKzdYuj0xhqImFBRPAJh9BBM.e1V-tRNo2j4Z0orHSFJDeF4o73UI7udnZn0MOco4TSpoYieIMg_yQHHZ0A

  5. Vor 16 Stunden · Proactive Investors - BAE Systems (LON: BAES) and Babcock (LON: BAB) have been awarded an order to build six new landing and assault craft for the Royal Marines. Grant Shapps, Defence Minister, said the new vessels would be Multi-Role Support Ships capable of launching drones and laser-targeted missiles as well as amphibious landing support.

  6. Vor 16 Stunden · Proactive Investors - Anthropic, an AI startup supported by Amazon (NASDAQ: AMZN ), announced the European launch of its AI assistant, Claude, available via web and iPhone app starting on Tuesday. Claude Pro, a subscription service providing access to advanced models like Claude 3 Opus, and business-oriented plans called Claude Team, priced at ...

  7. Vor 16 Stunden · 1.62%. On Tuesday, Wolfe Research adjusted its stance on Rapt Therapeutics (NASDAQ:RAPT), changing the rating from Outperform to Peerperform. The firm's analyst cited a continued belief in the scientific potential of the company's product and acknowledged the significant upside that remains for Rapt Therapeutics.